Quercetin Supplements: Human Evidence and Safety

A food contains many substances alongside quercetin. A concentrated capsule is a different exposure, and research formulations can differ from retail products. The apple and onion artwork represents dietary sources; it does not show a food amount equivalent to a supplement dose.^{See reference 1,See reference 3}

When evaluating a claim, identify the preparation, participants, duration and measured outcome. A finding for one extract cannot certify a different product, and a change in a blood marker cannot automatically establish fewer heart attacks or longer life.^{See reference 2,See reference 3}

The 2022 meta-analysis estimated an average systolic-pressure change of −2.38 mmHg (95% confidence interval −3.80 to −0.96). This pooled estimate combines particular trials and populations. It does not tell an individual which product to take or establish that a supplement can replace prescribed blood-pressure care.^{See reference 2}

The 2015 study used a specific onion-skin extract in overweight or obese adults with pre-hypertension or stage I hypertension. Its overall group had no significant blood-pressure benefit; a hypertensive subgroup showed a modest ambulatory systolic signal. The trial did not test heart attacks, survival or healthy lifespan.^{See reference 3}

The small 2019 pilot combined quercetin with dasatinib, a prescription medicine, in people with diabetic kidney disease. It measured changes in tissue and circulating markers after a short intervention. It had no blinded placebo comparison and did not isolate quercetin’s contribution.^{See reference 4}

Those findings are early biological evidence. They do not establish that quercetin alone is an effective anti-ageing treatment, and they do not justify copying a prescription-drug research protocol or applying it to healthy adults.^{See reference 4}

Memorial Sloan Kettering describes potential interactions with medicine-metabolising enzymes from laboratory experiments and with some medicines from preclinical work. Their clinical importance is uncertain. It also reports a warfarin case with increased INR, a clotting-test result, after quercetin supplementation. One case is a safety signal, not a measured risk for all users.^{See reference 1}

Bring the exact product and ingredient list to a pharmacist or clinician, especially if taking prescription medicines or receiving cancer treatment. Do not stop prescribed treatment to use quercetin. Short studies and preliminary signals do not establish a universally safe long-term dose.^{See reference 1}